Ai-Ris
Ai-Ris develops an automated retinal imaging system combining a portable headset and machine learning software to screen for multiple diseases including diabetic retinopathy, age-related macular degeneration (AMD), and Alzheimer's disease. Their technology enables general medical practitioners, including primary care providers and optometrists, to perform retinal screenings without specialists or pupil dilation. The system features automatic screening with minimal oversight, a non-mydriatic optical approach, and portability. Ai-Ris has secured over $400K in non-dilutive funding, amassed over 200K labeled retinal images for AI training, and holds a U.S. utility patent for their unique imaging technique. They are conducting clinical studies and aim to release a fully integrated hardware-software system by 2025, targeting affordable subscription pricing to expand access to eye care, especially in underserved communities.
Ai-Ris
Ai-Ris develops an automated retinal imaging system combining a portable headset and machine learning software to screen for multiple diseases including diabetic retinopathy, age-related macular degeneration (AMD), and Alzheimer's disease. Their technology enables general medical practitioners, including primary care providers and optometrists, to perform retinal screenings without specialists or pupil dilation. The system features automatic screening with minimal oversight, a non-mydriatic optical approach, and portability. Ai-Ris has secured over $400K in non-dilutive funding, amassed over 200K labeled retinal images for AI training, and holds a U.S. utility patent for their unique imaging technique. They are conducting clinical studies and aim to release a fully integrated hardware-software system by 2025, targeting affordable subscription pricing to expand access to eye care, especially in underserved communities.